RE: RNS3 Nov 2021 10:38
This is from the placing RNS dated 9th July 2021:
"Tom Kelly, CEO of Empyrean, commented on the Placing:
"We are very pleased to successfully complete this placing which provides the necessary funding to accelerate our preparation activities, including the securing of the rig, for the drilling of the extremely exciting Jade Prospect in China, which we are targeting to occur before the end of the 2021 calendar year, as well as providing working capital funding. The Placing Warrant structure with early exercise incentive Substitute and Bonus warrants also provides a mechanism by which the shareholders can potentially achieve a situation where the well is completely funded without the need for asset sales, joint venture or further placing. It puts the Company's destiny largely into the hands of shareholders. Whilst asset sales, joint venture or further placing are all worthwhile alternatives to drill Jade, it is the Company's view that the least dilutive solution, given that any asset sale may not settle before drilling starts, is for the remaining funds to come via warrant exercise. We look forward to updating shareholders on what is shaping up to be one of the most exciting wells drilled by a junior oil explorer this year."
This should also be added from the same RNS:
"The majority of the subscribers to the Placing were institutional and high net worth investors, including both new investors and existing shareholders, and also clients of First Equity Limited in the United Kingdom, who acted as UK manager to the Placing, and Petra Capital, who acted Australian manager to the Placing. Non-executive director of the Company, John (Spencer) Lay****, subscribed for 200,000 New Ordinary Shares in the Placing."
By now, with the original 3 month exercise period long gone, it is obvious that the warrants are not going to provide the necessary funding for this drill. In the real world, they never were, but the management seems to have a very distorted view of how " institutional and high net worth investors" like to spend their client's money. Interestingly only one of the directors even got involved. and then for only a pitifully small amount - 200,000 shares for £12,000, but even he has only taken up the option to exercise half - 100,000 - of his available warrants - for guess how much? - yes, £12,000.
So far, including during the 21 day extension, only 3,225,000 x 12p warrants have been exercised for a sum of £387,000 ($527,000). That is woefully short of the "significantly reduced drilling cost estimate of US$12.3m (previous estimate US$18.5m), plus a success-based testing cost estimate of US$7.4m".
With asset sales unlikely to be an option, and no mention of a JV, maybe it's about time that the management here came up with some real funding options.